ASCLETIS PHARMA INC (ASCLF:OTCMKTS)

$1.67 -0.472 (-22.0355%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 66

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ASCLETIS PHARMA INC (ASCLF:OTCMKTS) News Sources

Ascletis Pharma’s ASC36 Obesity Move Meets Strong Share Price Momentum

19-02-2026

yahoo.com

Sagimet Biosciences Highlights Denifanstat MASH Data, Combo Plans at Oppenheimer Healthcare Conf.

01-03-2026

marketbeat.com

Ascletis Announces Positive Topline Results from U.S. Phase II, 24-Week Study for Its Ultra-Long-Acting Subcutaneous Depot Formulations of Small Molecule GLP-1R Agonist ASC30 for Obesity

10-03-2026

yahoo.com

Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

11-03-2026

yahoo.com

Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results

25-03-2026

yahoo.com

Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

07-04-2026

yahoo.com

A Look At Ascletis Pharma SEHK:1672 Valuation After ASC30_39 Obesity Candidate Advances Toward US FDA IND

09-04-2026

yahoo.com

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

27-04-2026

yahoo.com

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

30-04-2026

yahoo.com

Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)

06-05-2026

yahoo.com

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) Sentiment Trend

0 25 50 75 100 90 76 24 65 67 69 88 54 63 67 19-02-2026 01-03-2026 10-03-2026 11-03-2026 25-03-2026 07-04-2026 09-04-2026 27-04-2026 30-04-2026 06-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) FAQs

toggle

What is the current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The current price of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is $1.67.


toggle

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is $-0.472.


toggle

ASCLETIS PHARMA INC (ASCLF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ASCLETIS PHARMA INC (ASCLF:OTCMKTS) since the previous trading day is -22.0355%.


toggle

What is the most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The most recent average sentiment score for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is 66 out of 100.


toggle

What is the most recent average sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS)?

The most recent sentiment for ASCLETIS PHARMA INC (ASCLF:OTCMKTS) is .


SEC-8K** Filing Available For ASCLETIS PHARMA INC (ASCLF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.